Managers / Q4 2018 · view latest →
Sofinnova Investments, Inc.
CIK 0001631134 · 3000 Sand Hill Road, BUILDING 3-SUITE 150, Menlo Park, CA, 94025 · 650.681.8428
Reported Value
$803M
Q4 2018
Positions
137
Filings on Record
33
2019–present window
Filed
Feb 22, 2019
amendment (RESTATEMENT)
Summary
Sofinnova Investments, Inc. reported $803M in U.S.-listed holdings across 137 positions for Q4 2018.
Its largest position, Ascendis Pharma A S, represents 11.7% of the portfolio.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
Composition data arrives with ticker enrichment.
Quarter-over-Quarter Changes full breakdown →
Holdings — Q4 2018
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $2.6B | 75 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $2.3B | 60 | Feb 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $1.8B | 62 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $1.6B | 63 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $1.5B | 65 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $1.4B | 61 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $1.3B | 62 | Nov 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $1.8B | 64 | Aug 15, 2024 | RESTATEMENT | changes · EDGAR ↗ |
| Q1 2024 | $1.8B | 74 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $1.8B | 64 | Feb 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $1.6B | 69 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $1.5B | 55 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $1.6B | 53 | May 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $1.69T | 53 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $1.7B | 61 | Nov 8, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $1.2B | 61 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $1.3B | 64 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $1.7B | 72 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $1.7B | 70 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $1.7B | 67 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $1.7B | 64 | May 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $1.7B | 69 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $1.3B | 157 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $1.6B | 186 | Aug 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $1.1B | 150 | May 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $1.4B | 135 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $1.1B | 167 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $1.1B | 163 | Aug 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $1.0B | 164 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $803M | 137 | Feb 22, 2019 | RESTATEMENT | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 2 additional managers.
- Crestline Management, LP028-14917
- Blackstone Alternative Asset Management L.P.
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.